ASHLEY MANN: Open Payments
NPI 1962931410 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,856 in 94 payments from 32 companies in 2025. Trend: 2023 $1,406 · 2024 $1,907 · 2025 $1,856
Food & beverage: $1,856
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $274 |
| Janssen Biotech, Inc. | 14 | $254 |
| Regeneron Healthcare Solutions, Inc. | 6 | $114 |
| Incyte Corporation | 4 | $87 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $87 |
| Merck Sharp & Dohme LLC | 4 | $85 |
| Genentech USA, Inc. | 4 | $71 |
| Daiichi Sankyo Inc. | 3 | $56 |
| Celgene Corporation | 3 | $55 |
| PharmaEssentia USA Corporation | 2 | $55 |
Products named: LIBTAYO, ERLEADA, Nubeqa, REBLOZYL, LUTATHERA, KEYTRUDA, MONJUVI, RYBREVANT.
Industry payments across AL — which companies pay providers there.
